Abstract
Prenatal hyperhomocysteinemia (PHHC) in pregnant rats was induced by chronic L-methionine loading, resulting in a significant increase in the L-homocysteine content both in the mothers’ blood and blood and brain of fetuses. Significant decrease in the weight of the placenta, fetus, and fetal brain was detected by the morphometric studies on day 20 of pregnancy. PHHC also activated maternal immune system due to the increase in the content of proinflammatory inter-leukin-1β in the rat blood and fetal part of the placenta. PHHC elevated the levels of the brain-derived neurotrophic factor (BDNF, 29 kDa) and nerve growth factor (NGF, 31 kDa) precursors in the placenta and the content of the BDNF isoform (29 kDa) in the fetal brain. The content of neuregulin 1 (NRG1) decreased in the placenta and increased in the fetal brain on day 20 of embryonic development. An increase in the caspase-3 activity was detected in the brains of fetuses subjected to PHHC. It was suggested that changes in the processing of neurotrophins induced by PPHC, oxidative stress, and inflammatory processes initiated by it, as well as apoptosis, play an important role in the development of brain disorders in the offspring.
Similar content being viewed by others
Abbreviations
- FPP:
-
fetal part of placenta
- HC:
-
homocysteine
- HHC:
-
hyperhomocysteinemia
- IL-1β:
-
interleukin-1β
- IL-6:
-
inter-leukin-6
- MPP:
-
maternal part of placenta
- NGF:
-
nerve growth factor
- NRG1:
-
neuregulin 1
- p75NTR:
-
p75 neurotrophin receptor
- PHHC:
-
prenatal hyperhomocysteinemia
- ROS:
-
reactive oxygen species
- TNF-α:
-
tumor necrosis factor α
References
Onore, C., Careaga, M., and Ashwood, P. (2012) The role of immune dysfunction in the pathophysiology of autism, Brain Behav. Immun., 26, 383–392; doi: 10.1016/j.bbi. 2011.08.007.
Patterson, P. H. (2009) Immune involvement in schizophrenia and autism: etiology, pathology and animal models, Behav. Brain Res., 204, 313–321; doi: 10.1016/j.bbr. 2008.12.016.
Wahlbeck, K., Forsen, T., Osmond, C., Barker, D. J., and Eriksson, J. G. (2001) Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood, Arch. Gen. Psychiatry, 58, 48–52; doi: 10.1001/archpsyc.58.1.48.
Dhobale, M. V., Pisal, H. R., Mehendale, S. S., and Joshi, S. R. (2013) Differential expression of human placental neurotrophic factors in preterm and term deliveries, Int. J. Dev. Neurosci., 31, 719–723; doi: 10.1016/j.ijdevneu. 2013.09.006.
Garces, M. F., Sanchez, E., Torres-Sierra, A. L., Ruiz-Parra, A. I., Angel-Muller, E., Alzate, J. P., Sanchez, A. Y., Gomez, M. A., Romero, X. C., Castaneda, Z. E., Sanchez-Rebordelo, E., Dieguez, C., Nogueiras, R., and Caminos, J. E. (2014) Brain-derived neurotrophic factor is expressed in rat and human placenta and its serum levels are similarly regulated throughout pregnancy in both species, Clin. Endocrinol. (Oxf.), 81, 141–151; doi: 10.1111/cen.12391.
Tapia-Arancibia, L., Rage, F., Givalois, L., and Arancibia, S. (2004) Physiology of BDNF: focus on hypothalamic function, Front. Neuroendocrinol., 25, 77–107; doi: 10.1016/j.yfrne.2004.04.001.
Tometten, M., Blois, S., and Arck, P. C. (2005) Nerve growth factor in reproductive biology: link between the immune, endocrine and nervous system? Chem. Immunol. Allergy, 89, 135–148; doi: 10.1159/000087962.
Dammann, O., Bueter, W., Leviton, A., Gressens, P., and Dammann, C. E. (2008) Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage, Neonatology, 93, 182–187; doi: 10.1159/000111119.
Esper, R. M., Pankonin, M. S., and Loeb, J. A. (2006) Neuregulins: versatile growth and differentiation factors innervous system development and human disease, Brain Res. Rev., 51, 161–175; doi: 10.1016/j.brainresrev.2005.11.006.
Arytjunyan, A. V., Milyutina, Yu. P., Zaloznyaya, I. V., Pustygina, A. V., Kozina, L. S., and Korenevskii, A. V. (2012) Use of different experimental models of hyperho-mocysteinemia in neurochemical studies, Neurochem. J., 6, 71–76; doi: 10.1134/S1819712411040027.
Zil’fyan, V. N., and Kumkumadzhyan, V. A. (1970) New technique for sampling blood from small laboratory animals, Zh. Eksp. Klin. Med., 10, 12–14.
Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248–254; doi: 10.1006/abio.1976.9999.
Bass, J. J., Wilkinson, D. J., Rankin, D., Phillips, B. E., Szewczyk, N. J., Smith, K., and Atherton, P. J. (2017) An overview of technical considerations for Western blotting applications to physiological research, Scand. J. Med. Sci. Sports, 27, 4–25; doi: 10.1111/sms.12702.
Arutjunyan, A., Kozina, L., Stvolinskiy, S., Bulygina, Y., Mashkina, A., and Khavinson, V. (2012) Pinealon protects the rat offspring from prenatal hyperhomocysteinemia, Int. J. Clin. Exp. Med., 5, 179–185.
Shcherbitskaya, A. D., Milyutina, Y. P., Zaloznyaya, I. V., Arutjunyan, A. V., Nalivaeva, N. N., and Zhuravin, I. A. (2017) The effects of prenatal hyperhomocysteinemia on the formation of memory and the contents of biogenic amines in the rat hippocampus, Neurochem. J., 11, 296–301; doi: 10.1134/s1819712417040080.
Koz, S. T., Gouwy, N. T., Demir, N., Nedzvetsky, V. S., Etem, E., and Baydas, G. (2010) Effects of maternal hyper-homocysteinemia induced by methionine intake on oxida-tive stress and apoptosis in pup rat brain, Int. J. Dev. Neurosci., 28, 325–329; doi: 10.1016/j.ijdevneu.2010.02.006.
Baydas, G., Koz, S. T., Tuzcu, M., and Nedzvetsky, V. S. (2008) Melatonin prevents gestational hyperhomocystein-emia-associated alterations in neurobehavioral developments in rats, J. Pineal Res., 44, 181–188; doi: 10.1111/j.1600-079X.2007.00506.x.
Baydas, G., Koz, S. T., Tuzcu, M., Nedzvetsky, V. S., and Etem, E. (2007) Effects of maternal hyperhomocystein-emia induced by high methionine diet on the learning and memory performance in offspring, Int. J. Dev. Neurosci., 25, 133–139; doi: 10.1016/j.ijdevneu.2007.03.001.
Makhro, A. V., Mashkina, A. P., Solenaya, O. A., Trunova, O. A., Kozina, L. S., Arutjunyan, A. V., and Bulygina, E. R. (2008) Prenatal hyperhomocysteinemia as a model of oxidative stress of the brain, Bull. Exp. Biol. Med., 146, 33–35; doi: 10.1007/s10517-008-0233-0.
Gerasimova, E., Yakovleva, O., Burkhanova, G., Khaertdinov, N., Sitdikova, G., and Ziyatdinova, G. (2017) Effects of maternal hyperhomocysteinemia on the early physical development and neurobehavioral maturation of rat offspring, BioNanoScience, 7, 155–158; doi: 10.1007/s12668-016-0326-6.
Makhro, A. V., Mashkinba, A. P., Solenaya, O. A., Trunova, O. A., Tyulina, O. V., Bulygina, E. R., and Boldyrev, A. A. (2008) Carnosine protects cells from oxidative stress induced by hyperhomocysteinemia, Neurochem. J., 2, 202–208; doi: 10.1134/S1819712408030112.
Tsitsiou, E., Sibley, C. P., D’Souza, S. W., Catanescu, O., Jacobsen, D. W., and Glazier, J. D. (2011) Homocysteine is transported by the microvillous plasma membrane of human placenta, J. Inherit. Metab. Dis., 34, 57–65; doi: 10.1007/s10545-010-9141-3.
Arutjunyan, A. V., Kozina, L. S., and Arutyunov, V. A. (2010) Toxic effect of prtenataly hyperhomocysteinemia on offsprings (experimental study), Zh. Akusher. Zhen. Bolez., 59, 16–23.
Arutjunyan, A. V., Pustygina, A. V., Milyutina, Yu. P., Zaloznyaya, I. V., and Kozina, L. S. (2015) Molecular markers of oxidative stress in offsprings in experimental hyperhomocysteinemia, Mol. Meditsina, 5, 41–46.
Pustygina, A. V., Milyutina, Yu. P., Zaloznyaya, I. V., and Arutjunyan, A. V. (2015) Indices of oxidative stress in the brain of newborn rats subjected to prenatal hyperhomocys-teinemia, Neurochem. J., 9, 60–65; doi: 10.1134/S1819712415010079.
Gitto, E., Pellegrino, S., Gitto, P., Barberi, I., and Reiter, R. J. (2009) Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin, J. Pineal Res., 46, 128–139; doi: 10.1111/j.1600-079X.2008.00649.x.
Da Cunha, A. A., Ferreira, A. G., Loureiro, S. O., da Cunha, M. J., Schmitz, F., Netto, C. A., and Wyse, A. T. (2012) Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats, Neurochem. Res., 37, 1660–1669; doi: 10.1007/s11064-012-0769-2.
Da Cunha, A. A., Ferreira, A. G., and Wyse, A. T. (2010) Increased inflammatory markers in brain and blood of rats subjected to acute homocysteine administration, Metab. Brain Dis., 25, 199–206; doi: 10.1007/s11011-010-9188-8.
Zanin, R. F., Bergamin, L. S., Morrone, F. B., Coutinho-Silva, R., de Souza Wyse, A. T., and Battastini, A. M. (2015) Pathological concentrations of homocysteine increases IL-1beta production in macrophages in a P2X7, NF-κB, and Erk-dependent manner, Purinergic Signal, 11, 463–470; doi: 10.1007/s11302-015-9464-5.
Xu, X., Yang, X. Y., He, B. W., Yang, W. J., and Cheng, W. W. (2016) Placental NRP1 and VEGF expression in pre-eclamptic women and in a homocysteine-treated mouse model of pre-eclampsia, Eur. J. Obstet. Gynecol. Reprod. Biol., 196, 69–75; doi: 10.1016/j.ejogrb.2015.11.017.
Bilbo, S. D., and Schwarz, J. M. (2009) Early-life programming of later-life brain and behavior: a critical role for the immune system, Front. Behav. Neurosci., 3; doi: 10.3389/neuro.08.014.2009.
Jakubowski, H. (2004) Molecular basis of homocysteine toxicity in humans, Cell. Mol. Life Sci., 61, 470–487; doi: 10.1007/s00018-003-3204-7.
Smith, S. E., Li, J., Garbett, K., Mirnics, K., and Patterson, P. H. (2007) Maternal immune activation alters fetal brain development through interleukin-6, J. Neurosci., 27, 10695–10702; doi: 10.1523/JNEUROSCI.2178-07. 2007.
Jander, S., Schroeter, M., and Stoll, G. (2000) Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia, J. Neuroimmunol., 109, 181–187; doi: 10.1016/s0165-5728(00)00317-9.
Onufriev, M. V., Freiman, S. V., Moiseeva, Yu. V., Stepanichev, M. Yu., Lazareva, N. A., and Gulyaeva, N. V. (2017) Accumulation of corticosterone and interleukin-1 in the hippocampus after focal ischemic damage of the neocortex: selective vulnerability of the ventral hippocampus, Neurochem. J., 11, 236–241, doi: 10.1134/S1819712417030084.
Bolton, J. L., and Bilbo, S. D. (2014) Developmental programming of brain and behavior by perinatal diet: focus on inflammatory mechanisms, Dialogues Clin. Neurosci., 16, 307–320.
Gilmore, J. H., Jarskog, L. F., and Vadlamudi, S. (2003) Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat, J. Neuroimmunol., 138, 49–55; doi: 10.1016/S0165-5728(03)00095-X.
Gilmore, J. H., Jarskog, L. F., and Vadlamudi, S. (2005) Maternal poly I:C exposure during pregnancy regulates TNFalpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat, J. Neuroimmunol., 159, 106–112; doi: 10.1016/j.jneuroim.2004.10.008.
Hsiao, E. Y., and Patterson, P. H. (2012) Placental regulation of maternal-fetal interactions and brain development, Dev. Neurobiol., 72, 1317–1326; doi: 10.1002/dneu. 22045.
Vega, J. A., Garcia-Suarez, O., Hannestad, J., Perez-Perez, M., and Germana, A. (2003) Neurotrophins and the immune system, J. Anat., 203, 1–19; doi: 10.1046/j.1469-7580.2003.00203.x.
Zhang, Y., Hodgson, N., Trivedi, M., and Deth, R. (2016) Neuregulin 1 promotes glutathione-dependent neuronal cobalamin metabolism by stimulating cysteine uptake, Oxid. Med. Cell. Longev., 2016, 3849087; doi: 10.1155/2016/3849087.
Fock, V., Plessl, K., Draxler, P., Otti, G. R., Fiala, C., Knofler, M., and Pollheimer, J. (2015) Neuregulin-1-mediated ErbB2-ErbB3 signalling protects human tro-phoblasts against apoptosis to preserve differentiation, J. Cell Sci., 128, 4306–4316; doi: 10.1242/jcs.176933.
Di Simone, N., Maggiano, N., Caliandro, D., Riccardi, P., Evangelista, A., Carducci, B., and Caruso, A. (2003) Homocysteine induces trophoblast cell death with apopto-tic features, Biol. Reprod., 69, 1129–1134; doi: 10.1095/biolreprod.103.015800.
Kamudhamas, A., Pang, L., Smith, S. D., Sadovsky, Y., and Nelson, D. M. (2004) Homocysteine thiolactone induces apoptosis in cultured human trophoblasts: a mechanism for homocysteine-mediated placental dysfunction? Am. J. Obstet. Gynecol., 191, 563–571; doi: 10.1016/j.ajog.2004. 01.037.
Fujita, K., Tatsumi, K., Kondoh, E., Chigusa, Y., Mogami, H., Fujii, T., Yura, S., Kakui, K., and Konishi, I. (2011) Differential expression and the anti-apoptotic effect of human placental neurotrophins and their receptors, Placenta, 32, 737–744; doi: 10.1016/j.placenta.2011. 07.001.
Yang, B., Ren, Q., Zhang, J. C., Chen, Q. X., and Hashimoto, K. (2017) Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis, Transl. Psychiatry, 7, e1128; doi: 10.1038/tp.2017.95.
Hashimoto, K. (2016) Regulation of brain-derived neurotrophic factor (BDNFßand its precursor proBDNF in the brain by serotonin, Eur. Arch. Psychiatry Clin. Neurosci., 266, 195–197; doi: 10.1007/s00406-016-0682-9.
Zeltser, L. M., and Leibel, R. L. (2011) Roles of the placenta in fetal brain development, Proc. Natl. Acad. Sci. USA, 108, 15667–15668; doi: 10.1073/pnas.1112239108.
Saenen, N. D., Plusquin, M., Bijnens, E., Janssen, B. G., Gyselaers, W., Cox, B., Fierens, F., Molenberghs, G., Penders, J., Vrijens, K., De Boever, P., and Nawrot, T. S. (2015) In utero fine particle air pollution and placental expression of genes in the brain-derived neurotrophic factor signaling pathway: an environage birth cohort study, Environ. Health Perspect., 123, 834–840; doi: 10.1289/ehp.1408549.
Dincheva, I., Lynch, N. B., and Lee, F. S. (2016) The role of BDNF in the development of fear learning, Depress. Anxiety, 33, 907–916; doi: 10.1002/da.22497.
Gerenu, G., Martisova, E., Ferrero, H., Carracedo, M., Rantamaki, T., Ramirez, M. J., and Gil-Bea, F. J. (2017) Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer’s neuropathology and cognitive deficits, Biochim. Biophys. Acta Mol. Basis Dis., 1863, 991–1001; doi: 10.1016/j.bbadis.2017.01.023.
Sasi, M., Vignoli, B., Canossa, M., and Blum, R. (2017) Neurobiology of local and intercellular BDNF signaling, Pflugers Arch., 469, 593–610; doi: 10.1007/s00424-017-1964-4.
Menshanov, P. N., Lanshakov, D. A., and Dygalo, N. N. (2015) ProBDNF is a major product of bdnf gene expressed in the perinatal rat cortex, Physiol. Res., 64, 925–934.
Patz, S., and Wahle, P. (2004) Neurotrophins induce short-term and long-term changes of cortical neurotrophin expression, Eur. J. Neurosci., 20, 701–708; doi: 10.1111/j.1460-9568.2004.03519.x.
Foltran, R. B., and Diaz, S. L. (2016) BDNF isoforms: a round trip ticket between neurogenesis and serotonin? J. Neurochem., 138, 204–221; doi: 10.1111/jnc.13658.
Kowianski, P., Lietzau, G., Czuba, E., Waskow, M., Steliga, A., and Morys, J. (2018) BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity, Cell. Mol. Neurobiol., 38, 579–593; doi: 10.1007/s10571-017-0510-4.
Mizui, T., Ishikawa, Y., Kumanogoh, H., and Kojima, M. (2016) Neurobiological actions by three distinct subtypes of brain-derived neurotrophic factor: multi-ligand model of growth factor signaling, Pharmacol. Res., 105, 93–98; doi: 10.1016/j.phrs.2015.12.019.
Garcia, K. L., Yu, G., Nicolini, C., Michalski, B., Garzon, D. J., Chiu, V. S., Tongiorgi, E., Szatmari, P., and Fahnestock, M. (2012) Altered balance of proteolytic iso-forms of pro-brain-derived neurotrophic factor in autism, J. Neuropathol. Exp. Neurol., 71, 289–297; doi: 10.1097/NEN.0b013e31824b27e4.
Mizui, T., Hattori, K., Ishiwata, S., Hidese, S., Yoshida, S., Kunugi, H., and Kojima, M. (2019) Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia, J. Psychiatr. Res., 113, 190–198; doi: 10.1016/j.jpsychires.2019.03.024.
Sahay, A. S., Jadhav, A. T., Sundrani, D. P., Wagh, G. N., and Joshi, S. R. (2019) Differential expression of nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF) in different regions of normal and preeclampsia placentae, Clin. Exp. Hypertens., 14, 1–5; doi: 10.1080/10641963.2019.1665677.
Xiong, J., Zhou, L., Yang, M., Lim, Y., Zhu, Y. H., Fu, D. L., Li, Z. W., Zhong, J. H., Xiao, Z. C., and Zhou, X. F. (2013) ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro, Neuro. Oncol., 15, 990–1007; doi: 10.1093/neuonc/not039.
Barcelona, P. F., and Saragovi, H. U. (2015) A pro-nerve growth factor (proNGF) and NGF binding protein, alpha2-macroglobulin, differentially regulates p75 and TrkA receptors and is relevant to neurodegeneration ex vivo and in vivo, Mol. Cell. Biol., 35, 3396–3408; doi: 10.1128/MCB.00544-15.
Budni, J., Bellettini-Santos, T., Mina, F., Garcez, M. L., and Zugno, A. I. (2015) The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease, Aging Dis., 6, 331–341; doi: 10.14336/AD.2015.0825.
Lebrun-Julien, F., Bertrand, M. J., De Backer, O., Stellwagen, D., Morales, C. R., Di Polo, A., and Barker, P. A. (2010) ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway, Proc. Natl. Acad. Sci. USA, 107, 3817–3822; doi: 10.1073/pnas.0909276107.
Fahnestock, M., Michalski, B., Xu, B., and Coughlin, M. D. (2001) The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer’s disease, Mol. Cell. Neurosci., 18, 210–220; doi: 10.1006/mcne.2001.1016.
Sahay, A. S., Sundrani, D. P., Wagh, G. N., Mehendale, S. S., and Joshi, S. R. (2015) Neurotrophin levels in different regions of the placenta and their association with birth outcome and blood pressure, Placenta, 36, 938–943; doi: 10.1016/j.placenta.2015.06.006.
Kim, K. C., Friso, S., and Choi, S. W. (2009) DNA methy-lation, an epigenetic mechanism connecting folate to healthy embryonic development and aging, J. Nutr. Biochem., 20, 917–926; doi: 10.1016/j.jnutbio.2009.06.008.
Kulkarni, A., Dangat, K., Kale, A., Sable, P., Chavan-Gautam, P., and Joshi, S. (2011) Effects of altered maternal folic acid, vitamin B12 and docosahexaenoic acid on placental global DNA methylation patterns in Wistar rats, PLoS One, 6, e17706; doi: 10.1371/journal.pone.0017706.
Funding
This work was supported by the Russian Foundation for Basic Research (project 18-015-00099) and by the State Budget Project no. AAAA-A19-119021290116-1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Additional information
Conflict of interest. The authors declare no conflict of interest in financial or any other sphere.
Russian Text © The Author(s), 2020, published in Biokhimiya, 2020, Vol. 85, No. 2, pp. 248-259.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM19-137, December 16, 2019.
Rights and permissions
About this article
Cite this article
Arutjunyan, A.V., Milyutina, Y.P., Shcherbitskaia, A.D. et al. Neurotrophins of the Fetal Brain and Placenta in Prenatal Hyperhomocysteinemia. Biochemistry Moscow 85, 213–223 (2020). https://doi.org/10.1134/S000629792002008X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S000629792002008X